breakpoints at the nucleotide level without relying on the discordant mapping of paired-end reads. By definition, a sequence read that spans a bona fide SV will have partial alignment to each of the two sides of the junction (Fig. 1a) . Current next-generation sequencing mapping algorithms such as that Burrows-Wheeler alignment tool 10 compute local alignment (partial alignment) for a read either automatically when its mate is globally aligned to the genome or by user request. The unaligned portion is masked by a process termed 'soft-clipping' because the unaligned subsequence is retained but not trimmed even though it does not map to the current genomic location (Fig. 1b) . With longer next-generation sequencing read length (≥ 75 bp), these soft-clipped subsequences can be of sufficient length to map unambiguously to a different genomic location, thus identifying the second breakpoint for a putative SV.
Based on this concept, we developed 'clipping reveals structure' (CREST), a software tool that uses the soft-clipped reads to directly map the breakpoints of SVs. For each SV, we identified the first breakpoint by the presence of soft-clipped reads and found its partner by an assembly-mapping-searching-assembly-alignment procedure ( Fig. 1c and Online Methods). We classified the identified SVs into the following five subtypes based on location and orientation of the breakpoints: interchromosomal translocations, intrachromosomal translocations, inversions, deletions and insertions ( Supplementary Figs. 1 and 2) .
We applied CREST to whole-genome DNA sequence data obtained from five childhood T-lineage acute lymphoblastic leukemia (T-ALL) samples with matched 'normal' (for example, bone marrow samples obtained at remission) samples that had been sequenced as part of the St. Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project. This analysis identified a total of 110 SVs (Supplementary Table 1) , including 36 interchromosomal translocations, 25 intrachromosomal translocations, 1 inversion, 26 deletions and 22 insertions. We designed PCR primers for 107 (97%) of the predicted SVs, and Sanger sequencing of the generated amplicons from the respective tumors confirmed 89 of the predicted SV breakpoints (82% validation rate; Fig. 2a) . Across the five samples, the validated SVs included 31 interchromosomal translocations, 19 intrachromosomal translocations, 1 inversion, 22 deletions and 16 insertions. The validated translocations detected through CREST ranged from balanced translocations to highly complex rearrangements that involved multiple chromosomes. In a representative example, we defined a complex rearrangement involving chromosomes 1, 4, 5 and 10 in one sample (Fig. 2b-f) .
To compare the performance of CREST to that of other available algorithms, we first reanalyzed this dataset using BreakDancer 5 , a commonly used tool that implements a paired-end discordance crest maps somatic structural variation in cancer genomes with base-pair resolution We developed 'clipping reveals structure' (crest), an algorithm that uses next-generation sequencing reads with partial alignments to a reference genome to directly map structural variations at the nucleotide level of resolution. application of crest to whole-genome sequencing data from five pediatric t-lineage acute lymphoblastic leukemias (t-aLLs) and a human melanoma cell line, coLo-829, identified 160 somatic structural variations. experimental validation exceeded 80%, demonstrating that crest had a high predictive accuracy.
Somatically acquired structural variations (SVs) can induce alterations in genes that directly contribute to cellular transformation 1 . Transcriptome 2 and whole-genome-sequence 3,4 analyses of tumor and matched germline samples have led to a marked improvement in our ability to identify SVs in cancer. Nevertheless, the accurate identification of SVs using next-generation sequencing remains challenging. In these analyses, typically 30-100 bp reads from the two ends of a sequence fragment are obtained and mapped to the reference human genome; discordances in distance, orientation and/or mapping status (for example, whether a read is mapped or unmapped to the reference genome) are used to identify SVs [5] [6] [7] [8] [9] . These approaches only infer the approximate genomic locations of an SV but do not pinpoint their exact breakpoint at the nucleotide level. Moreover, the available methods tend to generate a high frequency of false positives when applied to experimental data because of the presence of PCR and/or sequencing artifacts and the inherent difficulty of accurately mapping sequences in repetitive regions.
To overcome some of these deficiencies, we explored an alternative approach for SV discovery that is based on directly mapping SV nature methods | VOL.8 NO.8 | AUGUST 2011 | 653 brief communications mapping algorithm. BreakDancer identified only 27 out of the 89 validated SVs that we defined using CREST. Moreover, although BreakDancer identified another 1,037 putative SVs, none of these survived a postprocessing quality check and thus were false positive predictions. A second paired-end discordance mapping algorithm, geometric analysis of structural variants, detected 76 (85%) of the validated SVs among 5,880,492 predictions, demonstrating that this relatively low false negative rate was achieved with a cost of an extremely high false positive rate. Reanalysis using Pindel 11 , a program that uses unmapped reads across insertion-deletion (indel) breakpoints, detected only five of the 89 validated SVs found by CREST, suggesting that different methods are required for finding gross SVs and indels. We compared the performance of CREST to that of other algorithms in Supplementary Data 1.
Next we tested CREST on a published whole-genome sequencing dataset from the metastatic melanoma cancer cell line . Using a paired-end discordant mapping method 3 , the published analysis had reported 37 validated SVs 12 . By comparison, CREST identified 76 SVs (Supplementary Data 2 and Supplementary Table 2) including 26 of the 37 reported SVs. Of the 11 reported SVs that CREST did not identify, six had softclipped reads in the matching normal sample COLO-829BL, indicating that these six SVs were germline polymorphisms but not tumor-specific somatic SVs. Of the five remaining SVs, three lacked soft-clipped reads, one had soft-clipped reads that mapped to multiple genomic locations and one had low-quality softclipped reads across the breakpoints. CREST identified 50 additional SVs in this dataset that had not been reported previously 12 . We selected 20 of these SVs for validation and PCR-amplified DNA extracted from the COLO-829 cell line (Supplementary Table 3 ). We validated 18 of the 20 selected SVs, which included 7 interchromosomal translocations, 9 deletions and 2 insertions by Sanger sequencing (Supplementary Figs. 3 and 4) .
To assess the false negative rate of CREST in identifying germline SVs, we simulated whole-genome sequencing data for the 887 copy-number variations in the genome of NA12878, one of the individuals characterized in the 1000 Genomes Project by applying 19 different SV detection methods to high-coverage sequencing data generated using three different platforms 13 . The false negative rate of CREST was 22-27% with 3% false positive calls, demonstrating its superior performance in both sensitivity and accuracy compared with BreakDancer and Pindel (Supplementary Table 4 ). Fifty-two percent of the copy-number variations missed by CREST were in regions of segmental duplications where germline copy-number variations are frequent (26% of NA12878) but somatically acquired copy-number alterations are rare (6% of the copy-number alterations in five T-ALLs) based on the data analyzed in this study, suggesting that the false negative rate of somatic copy-number alterations could be lower than that of germline copy-number variations. Results of this analysis are available in Supplementary Data 3.
Although the concept of using sequences that span breakpoints has been previously explored for finding chimeric mRNAs 2 , for mapping viral integration sites by targeted sequencing 14 and for identifying indels 11 , CREST, to our knowledge, is the first use of this approach for mapping SVs in whole-genome data. CREST is particularly well suited for identifying somatically acquired SVs in paired tumor and normal samples, where its precision in finding the breakpoints coupled with its integrated ability to subtract common variations present in both germline and tumor samples also allows the removal Reference genome sequence is at the top and next-generation sequencing reads are shown below it with highlighted mismatches to the reference (red letters) and soft-clipping subsequences not aligned to the reference (gray letters). Upper-case letters represent highquality bases (phred score ≥20) and the darkness of shading correlates to lower quality score. In this example, the soft-clipping subsequences map to chromosome X, revealing a chromosome 2 to chromosome X translocation. (c) The five-step CREST algorithm: extraction of soft-clipped reads in the binary alignment/map (bam) file; assembly of soft-clipped reads at a putative breakpoint into a contig; mapping of the contig against the reference genome to identify candidate partner breakpoints; identification of all possible softclipped reads and assembly into a contig; and alignment of the contig derived from the partner back to the reference genome. A match to the initial breakpoint is considered a SV.
of false lesions caused by the artifacts generated during library construction and the difficulties inherent in accurately mapping short sequence reads. Other computational methods for detecting SV did not outperform CREST in our comparative analysis (Supplementary Data 1) . Moreover, methods specifically designed to identify germline deletions 15 cannot find inter-and intrachromosomal rearrangements, which are key mechanisms for creating oncogenic fusion proteins in cancer. The entire CREST package can be downloaded from http://www. stjuderesearch.org/site/lab/zhang with a user manual and test data. Although CREST performs better than standard paired-end approaches in identifying SVs, it has difficulty with analyzing repetitive DNA sequence regions, rearrangements that occur within or next to germline polymorphic SVs, and rearrangements that contain nontemplate DNA sequences that are inserted at the breakpoints and are of similar or longer length than the next-generation sequencing reads. CREST, like all mapping methods, demands high-quality DNA reads of sufficient coverage to accurately define the DNA sequence (Supplementary Discussion). The method provides base-pair resolution of breakpoints and can therefore be used not only for identifying the number and type of SVs in a tumor genome but should also allow an analysis of the breakpoint DNA sequence as a way to gain insights into the mechanism responsible for the generation of the structural rearrangement. onLine methods Whole-genome sequencing data. DNA samples were obtained from diagnostic bone marrow aspirates from five children with T-ALL and from matched remission bone marrow samples from each individual (as 'normal' controls). The samples were obtained following informed consent given by the individual (if over the age of majority), their parent or guardian. The study was approved by the Institutional Review Boards of both St. Jude Children's Research Hospital and Washington University. The DNA samples were paired-end-sequenced on an Illumina GAIIX using DNA fragments with 300-500 bp insert size and DNA sequence reads 100 bp, as previously described 4 . The mean coverage for the tumor genomes was 32-to 34-fold and that of the matching 'normal' genomes was 24-to 28-fold. All reads were mapped to the human assembly US National Center for Biotechnology Information (NCBI) build 36 using the Burrows-Wheeler alignment tool (BWA) 10 with the default parameters. In addition to this primary DNA sequence data, paired tumor and 'normal' wholegenome sequencing data from the malignant melanoma cell line COLO-829 were obtained from the Sanger Center in the format of binary alignment/map (bam) files 12 , which store the read alignments to the human assembly NCBI build 36.
CREST algorithm and SV analysis pipeline. The SV analysis pipeline using CREST is shown in Supplementary Figure 2 . Input data can either be two bam files representing paired tumor and 'normal' samples or a single bam file. Germline variations are filtered in the paired analysis.
The SV detection algorithm first collects all soft-clipped reads, coded as 'S' in the compact idiosyncratic gapped alignment report (CIGAR) string into a bam format file. The soft-clipped reads are then used to define putative SV breakpoints that meet the following criteria: (i) the number of soft-clipped reads (c) and the sequence coverage (C) by including reads with >97% sequence identity and a minimum Blat score of 30; or (ii) the probability of observing at least c soft-clipped reads with the coverage C is greater than 0.05 based on a binomial distribution of observing a heterozygous SV at a user-specified heterogeneity factor. Many putative SV breakpoints have soft-clipped reads as well as wild-type reads because SVs usually occur either in a subset of tumors owing to tumor heterogeneity and/or are heterozygous events. Therefore, with the exception for homozygous deletion events, there are usually two groups of reads at a putative breakpoint. Using binomial distribution allows us to evaluate the significance of observing c number of soft-clipped reads (one group) given the coverage (the wild-type group) at the site. Use of the second criterion ensures that statistically significant SVs (P < 0.05) are retained even if they do not meet the ad hoc user-defined criteria regions in which the next-generation sequencing coverage is low.
Each putative breakpoint is considered to be the first breakpoint of a potential SV. The corresponding partner breakpoint is identified by applying an assembly-mapping-searching-assembly-alignment procedure consisting of CAP3 (ref. 16 ) for assembly and Blat 17 for genomic search and alignment. If the alignment shows high identity (default set to 90%) between the second contig and the first breakpoint, then the two breakpoints are considered to form a putative SV. The identified putative SVs are then filtered to remove false positives owing to alignment artifacts by the following process. For each SV, the distance between the second contig to the first breakpoint is required to be within a short distance (user-definable, default set to 15 bp) to ensure it maps back to the first breakpoint. For a paired analysis that uses both germline and somatic data, presence of an SV in the germline sample is evaluated by extracting germline reads that have soft-clipped bases at the SV breakpoints and re-aligning them by Blat to the second contig. This step ensures that a germline SV that may have slightly different soft-clipping position from its somatic counterpart is not classified as a somatic event.
CREST exports three output files: (i) a report file that records the breakpoints of SVs at base-pair resolution, number of softclipping reads and genes located across the breakpoints; (ii) a template file for experimental validation with 1,000 flanking nucleotides of each breakpoint; and (iii) an extensible markup language (XML) output file that displays the assembled contigs for users who are interested in visually inspecting the predicted SVs. Manual review is optional. The XML file displays alignment of the reads across the breakpoints, quality score of each base and the soft-clipping signature (Supplementary Figs. 5-10) . The entire package can be downloaded from http://www.stjuderesearch.org/ site/lab/zhang with a user manual and test data.
Post-process of structure variations predicted by BreakDancer.
For each predicted SV, we first checked whether discordant mapping of paired-end reads was caused by repetitive regions in the human genome. All supporting reads are extracted in fastq format and each read is re-mapped to the hg18 reference genome using Blat. If a read-pair is mapped within the library insert range (mean insert size ± 3 s.d.), it will not be considered a supporting read pair for the SV. All SVs with ≥ 3 supporting read pairs and BreakDancer score ≥ 30 after remapping were retained and the 'tumor-only' SVs are considered putative somatic SVs. The putative somatic SVs were then subjected to an assembly process to evaluate their validity because a valid SV should have at least one cross-junction contig. All reads mapped within 1 kb of the two breakpoints along with their unmapped mate pairs are extracted. The mapping information was based on the bam files. We then ran phrap to assemble the extracted sequences into contigs by using base call, quality value and paired-end information. Assembly was carried out in two iterations because the first iteration usually generates contigs that represent the wild-type allele unless the alternative allele is a homozygous genomic change. The second iteration starts with reads not assembled in the first iteration, which generates contigs for the heterozygous alternative allele. All contigs were mapped to the reference human genome using Blat. If a contig had two distinct parts (that is, two regions with minimum overlap) mapped to two different genomic regions with high similarity (≥ 97%) and good read length (≥ 30 bp), it was considered a cross-junction contig. Once such a contig was identified and there were no germline reads mapped to the breakpoints identified in the Blat alignment, the SV was considered an assembly-validated somatic SV.
Estimation of somatic indels across the five T-ALL tumors based on background mutation rate in childhood cancer. Background mutation rate (BMR) for adult glioblastoma multiforme was estimated to be 3.75 × 10 −6 based on synonymous mutations identified in the protein-coding regions 18 . A recent study of childhood cancer medulloblastoma indicates that childhood cancer has fewer somatic mutations by a factor of 5 to 10 than in the adult tumors 19 , resulting in a background mutation rate of 7.5 × 10 −6 to 3.75 × 10 −7 for childhood cancer. Our analysis of 120 candidate gene sequencing data of 187 children with leukemia showed that the BMR of childhood ALL is within the estimated range but closer to the lower end of the estimate (Zhang, J., Mullighan, C.G., Harvey, R.C., Wu, G., Chen, X. et al., unpublished data). As the estimated BMR was based on substitution variations but somatic indels were approximately one-tenth of that of the substitution mutations 18 , the somatic indel mutation rate in childhood cancer is projected to be 7.5 × 10 −7 to 3.75 × 10 −8 . Applying the indel mutation rate to the entire human genome gives an estimated 112-225 somatic indels per tumor. Therefore, the total number of somatic indels across the five T-ALL tumors is estimated to be 562-1,125.
Preparation of simulated whole-genome sequencing data for NA12878. Simulated whole-genome sequencing data were generated to evaluate the sensitivity of CREST in identifying validated germline SVs (deletions, duplications and insertions) compiled as a gold standard dataset by the 1000 Genomes Project 13 . NA12878 was selected because the genome was sequenced at high coverage using three sequencing platforms (Solexa (Illumina), 454 (Roche) and SOLiD (Life Technologies)) and analyzed by 19 SV detection methods, 12 of which were evaluated for their sensitivity in detecting deletion polymorphisms. The gold-standard dataset for NA12878 consists of 642 deletions, 271 duplications and 30 insertions. We could not include the 30 insertions for simulation because the inserted sequences were not accessible. Of the 913 deletion-duplication events, 309 at 138 loci are overlapping events with multiple nonreference deletion-duplication alleles. We considered these multiallele polymorphisms with ≥ 2 nonreference alleles in the population. Two haploid genomes were generated to represent the two nonreference deletion-duplication alleles in these regions. For the 26 loci that had ≥ 3 overlapping nonreference alleles, two were randomly selected resulting in a loss of 27 events (23 deletions and 4 duplications). We simulated 100-bp paired-end reads with a mean size of 400 bp with a s.d. of 20 bp using the software MAQ (version 0.7.1) 20 and obtained 20-fold coverage to human assembly NCBI build 36 for each haploid genome. Merging the data from the two haploid genomes gave 1,232,167,792 reads for the diploid genome data with a mean coverage of 40. All reads were mapped to the human assembly NCBI build 36 using the program BWA 10 with default parameters.
Two sets of whole-genome simulation data were generated based on the following two quality models. One is a normal quality simulation that derives the sequencing error and quality based on a training dataset of 250,000 empirical reads randomly selected from our T-ALL whole-genome sequencing (WGS) data, and the other is a high-quality dataset that uses only reads with qualities in the range of 32-40 for training. We created the high-quality simulation data because the mapping rate of the normal quality WGS was 10% lower than that of the empirical WGS data for the 10 T-ALL genomes, which ranged from 92% to 95%. High-quality simulation data had a mapping rate of 91%, which is close to the empirical mapping rate.
Experimental validation. The COLO-829 cell line was purchased from the American Type Culture Collection (ATCC). Oligonucleotide primers for genomic PCR were designed using Primer 3 (http://frodo.wi.mit.edu/primer3/). Genomic DNA from T-ALL tumor samples and COLO-829 was PCR amplified using either the Advantage 2 PCR kit (Clontech) or Phusion High-Fidelity DNA polymerase (New England Biolabs). Thermal cycling conditions for Advantage 2 polymerase were 5 cycles of 94 °C for 30 s and 72 °C 3 min, followed by 5 cycles of 94 °C for 30 s, 70 °C for 30 s and 72 °C 3 min, followed by 25 cycles of 94 °C for 30 s, 68 °C for 30 s and 72 °C 3 min; and for Phusion were 98 °C for 30 s, followed by 35 cycles of 98 °C for 15 s, 66 °C for 15 s and 72 °C for 1 min, followed by a final extension step of 72 °C for 10 min. PCR products were electrophoresed through 1% agarose gels impregnated with Gel Red, visualized using UV-light illumination and purified directly from PCR mixtures or after gel electrophoresis. Purified PCR products were sequenced using 3730xl capillary sequencers and Big Dye terminator chemistry (Applied Biosystems).
Mapping algorithms for CREST analysis. As a soft-clipping signature that represents a partial (local) alignment to the reference genome is a prerequisite for CREST analysis, output from mapping tools with local alignment function (such as Mosaik (http://bioinformatics.bc.edu/marthlab/Mosaik) and Blat-like fast accurate search tool (BFAST) (http://sourceforge.net/projects/ bfast/)) can be used after proper reformatting for this analysis. In contrast, mapping methods that only perform global alignments such as ELAND (Illumina Genome Analyzer Pipeline Software) and bowtie (http://bowtie-bio.sourceforge.net/index.shtml) will not be able to provide a suitable soft-clipping signature.
